Matching-Adjusted Indirect Comparison of the Efficacy at Week 32 of Tralokinumab and Dupilumab in the Treatment of Moderate-to-Severe Atopic Dermatitis

Abstract Introduction Tralokinumab and dupilumab are biological agents licensed for the treatment of moderate-to-severe atopic dermatitis (AD) in adult patients who are candidates for systemic treatment. However, no head-to-head studies of their efficacy have been conducted. This study indirectly co...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Tiago Torres (Автор), Anne Sohrt Petersen (Автор), Ulla Ivens (Автор), Albert Bosch Vilaro (Автор), John Stinson (Автор), José Manuel Carrascosa (Автор)
Формат:
Опубликовано: Adis, Springer Healthcare, 2024-04-01T00:00:00Z.
Предметы:
Online-ссылка:Connect to this object online.
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Internet

Connect to this object online.

3rd Floor Main Library

Подробно о фондах из 3rd Floor Main Library
Шифр: A1234.567
Копировать 1 Доступно